Cortendo AB To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum In San Francisco October 7, 2014

Regulatory News:

Cortendo AB [ticker: CORT on NOTC-A], a biopharmaceutical company developing and commercializing products at the intersection of orphan diseases and endocrinology disorders, today announced that Matthew Pauls, President and CEO, will present at the 13th Annual BIO Investor Forum. The presentation is at the Palace Hotel in the Sea Cliff room on Oct. 7, 2014, at 3:00 p.m. PST in San Francisco, CA.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC